Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
SAN DIEGO & BRISTOL, Tenn. & TIVERTON, R.I.----Santarus, Inc. , S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET® tablets in the U.S.
Read more...
Decreasing pituitary's sensitivity to insulin could be new target for infertility treatment
Obese women have a well-known risk for infertility, but a new Johns Hopkins Children's Center study has unraveled what investigators there believe is the mechanism that accounts for the risk.
Read more...
|